Device type · CIX
Bromcresol Green Dye-Binding, Albumin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CIX
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
7
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Bromcresol Green Dye-Binding, Albumin
- Product code
- CIX
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1035
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CIX
Latest FDA decisions
- Core Metabolic510(k)
K251157 · Decided Jan 9, 2026 · 269 days after receipt
Device type: Bromcresol Green Dye-Binding, Albumin (CIX) · Laboratory Medicine & Pathology
- Albumin BCG2510(k)
Abbott Ireland Diagnostics Division
K203248 · Decided Nov 23, 2021 · 384 days after receipt
Device type: Bromcresol Green Dye-Binding, Albumin (CIX) · Laboratory Medicine & Pathology
K200898 · Decided Sep 21, 2021 · 536 days after receipt
Device type: Bromcresol Green Dye-Binding, Albumin (CIX) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Reports received
7
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
7
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 2 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings2
- Low Test Results2
- Non Reproducible Results2
1 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions7
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Ortho-Clinical Diagnostics, Inc.
Z-2684-2024 · Started Jul 10, 2024 · Posted by FDA Aug 16, 2024
Reason given: The reason for this recall is QuidelOrtho has determined that during normal use the VITROS XT ALB-TP Slides may shed dust and debris as they travel through the MicroSlide Subsystem of the VITROS XT 3400 or VITROS XT 7600 analyzer. This dust and debris may then settle onto VITROS Na+ (Sodium) Slides as they are...
Cause as FDA categorized it: Under Investigation by firm
- Albumin Gen.2, Catalog 05166861190Terminated
Roche Diagnostics Operations, Inc.
Z-0104-2021 · Started Aug 27, 2020
Reason given: Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
Cause as FDA categorized it: Under Investigation by firm
Roche Diagnostics Operations, Inc.
Z-0152-2020 · Started Sep 11, 2019 · Posted by FDA Oct 16, 2019
Reason given: Due to low Quality Control recovery and invalid Calibration.
Cause as FDA categorized it: Under Investigation by firm
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.